» Articles » PMID: 30892696

Peptoid Drug Discovery and Optimization Via Surface X-ray Scattering

Overview
Journal Biopolymers
Publisher Wiley
Date 2019 Mar 21
PMID 30892696
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Synthetic polymers mimicking antimicrobial peptides have drawn considerable interest as potential therapeutics. N-substituted glycines, or peptoids, are recognized by their in vivo stability and ease of synthesis. Peptoids are thought to act primarily on the negatively charged lipids that are abundant in bacterial cell membranes. A mechanistic understanding of lipid-peptoid interaction at the molecular level will provide insights for rational design and optimization of peptoids. Here, we highlight recent studies that utilize synchrotron liquid surface X-ray scattering to characterize the underlying peptoid interactions with bacterial and eukaryotic membranes. Cellular membranes are highly complex, and difficult to characterize at the molecular level. Model systems including Langmuir monolayers, are used in these studies to reduce system complexity. The general workflow of these systems and the corresponding data analysis techniques are presented alongside recent findings. These studies investigate the role of peptoid physicochemical characteristics on membrane activity. Specifically, the roles of cationic charge, conformational constraint via macrocyclization, and hydrophobicity are shown to correlate their membrane interactions to biological activities in vitro. These structure-activity relationships have led to new insights into the mechanism of action by peptoid antimicrobials, and suggest optimization strategies for future therapeutics based on peptoids.

Citing Articles

Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies.

Bahatheg G, Kuppusamy R, Yasir M, Black D, Willcox M, Kumar N Antibiotics (Basel). 2022; 11(8).

PMID: 36009943 PMC: 9404767. DOI: 10.3390/antibiotics11081074.


"Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry.

Shukla S, Cho K, Rustagi V, Gao X, Fu X, Zhang S Int J Mol Sci. 2021; 22(16).

PMID: 34445669 PMC: 8396575. DOI: 10.3390/ijms22168963.


Structural Changes in Films of Pulmonary Surfactant Induced by Surfactant Vesicles.

Andreev K, Martynowycz M, Kuzmenko I, Bu W, Hall S, Gidalevitz D Langmuir. 2020; 36(45):13439-13447.

PMID: 33080138 PMC: 8754419. DOI: 10.1021/acs.langmuir.0c01813.


The Best Peptidomimetic Strategies to Undercover Antibacterial Peptides.

Lachowicz J, Szczepski K, Scano A, Casu C, Fais S, Orru G Int J Mol Sci. 2020; 21(19).

PMID: 33027928 PMC: 7583890. DOI: 10.3390/ijms21197349.

References
1.
Kumar D, Choi S, Washicosky K, Eimer W, Tucker S, Ghofrani J . Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med. 2016; 8(340):340ra72. PMC: 5505565. DOI: 10.1126/scitranslmed.aaf1059. View

2.
Wieprecht T, Dathe M, Beyermann M, Krause E, Maloy W, MACDONALD D . Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry. 1997; 36(20):6124-32. DOI: 10.1021/bi9619987. View

3.
Chung M, Lowe R, Chan Y, Ganesan P, Boxer S . DNA-tethered membranes formed by giant vesicle rupture. J Struct Biol. 2009; 168(1):190-9. PMC: 2757119. DOI: 10.1016/j.jsb.2009.06.015. View

4.
Foged C, Franzyk H, Bahrami S, Frokjaer S, Jaroszewski J, Nielsen H . Cellular uptake and membrane-destabilising properties of alpha-peptide/beta-peptoid chimeras: lessons for the design of new cell-penetrating peptides. Biochim Biophys Acta. 2008; 1778(11):2487-95. DOI: 10.1016/j.bbamem.2008.06.020. View

5.
Ivankin A, Apellaniz B, Gidalevitz D, Nieva J . Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol. Biochim Biophys Acta. 2012; 1818(11):2521-8. PMC: 8796276. DOI: 10.1016/j.bbamem.2012.06.002. View